Re-watch our webinar on “New Evidence in the Treatment of HBR Patients: Balance of Ischemic and Bleeding Risks” on our YouTube channel.
During the event, Dr. Marco Valgimigli, principal investigator of the MASTER DAPT trial, shared the main outcomes of that study and had an interesting academic debate with Drs. Anibal Damonte (ARG), Mario Araya (CHI), Alejandro Martinez (CHI), Jorge Mor (COL), and Fernando Cura (ARG).
The event was attended by 250 spectators and was sponsored by both the South American Society of Cardiology and the Terumo company.
New Evidence in the Treatment of HBR Patients: Balance of Ischemic and Bleeding Risks
Subscribe to our weekly newsletter
Get the latest scientific articles on interventional cardiology